title: Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.
abstract: The telomere-telomerase hypothesis states that the vast majority of human tumors have a prolonged replicative life span throughout expressing telomerase, which compensates the cell division-associated loss of telomere DNA. The use of telomere length and telomerase expression as new biological markers in cancer patients requires their correlation with disease prognosis. We, therefore, correlated the mean telomere length based on a telomere restriction fragment assay and the activity of telomerase measured with a telomeric repeat amplification protocol with clinical data and overall survival in 58 patients with B cell chronic lymphocytic leukemia (B-CLL). Telomere length showed a highly inverse correlation to telomerase activity. Patients with telomeres below 6.0 kb were associated with high telomerase activity, whereas patients with a telomere length >6.0 kb generally showed low enzyme activity (P <0.001). Patients in Binet A exhibited significantly longer telomeres and had less telomerase activity than did patients in Binet B or Binet C, where significantly shorter telomeres and higher telomerase activity were observed (P=0.031). Short telomere length and high telomerase activity were significantly associated with a shorter median survival (P=0.02 and P <0.001), and telomerase activity was the most significant prognostic factor for overall survival in B-CLL (P <0.001). Our data provide evidence that telomere length, as well telomerase activity, exerts a strong impact on the survival of B-CLL patients and that telomerase activity can be used as a new prognostic marker in this disease.
authors.affiliation: Department of General Internal Medicine, Innsbruck University Hospital, Austria. Oliver.Bechter@uibk.ac.at
authors.forename: O E
authors.initials: OE
authors.lastname: Bechter
authors.forename: W
authors.initials: W
authors.lastname: Eisterer
authors.forename: G
authors.initials: G
authors.lastname: Pall
authors.forename: W
authors.initials: W
authors.lastname: Hilbe
authors.forename: T
authors.initials: T
authors.lastname: Kühr
authors.forename: J
authors.initials: J
authors.lastname: Thaler
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000201:enzymology / Q000235:genetics* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D015996:Survival Rate; D019098:Telomerase / Q000378:metabolism*; D016615:Telomere
chemical_list: D019098:Telomerase